Antiangiogenic agents

Suppl Tumori. 2002 Jul-Aug;1(4):S39-43.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / blood supply*
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Clinical Trials as Topic
  • Cyclooxygenase 2
  • Enzyme Inhibitors / therapeutic use
  • Epidermal Growth Factor / antagonists & inhibitors
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Lung Neoplasms / blood supply*
  • Lung Neoplasms / drug therapy
  • Matrix Metalloproteinase Inhibitors
  • Membrane Proteins
  • Neovascularization, Pathologic / drug therapy*
  • Prostaglandin-Endoperoxide Synthases
  • Receptor, ErbB-2 / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Isoenzymes
  • Matrix Metalloproteinase Inhibitors
  • Membrane Proteins
  • Epidermal Growth Factor
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Receptor, ErbB-2